![]() La Jolla Pharmaceutical Company La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer. | Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | ![]() Innovative Cellular Therapeutics Innovative Cellular Therapeutics (ICT, 斯丹赛生物技术) is a biotechnology company focused on the development of cellular immunotherapies for the treatment of cancer. | ![]() Captor Therapeutics Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases. | ||
Founding Date | Founding Date 1989 | Founding Date 2002 | Founding Date 2008 | Founding Date 2009 | Founding Date 2017 |
Type | Type Public | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ San Diego, US San Diego, US | Locations Hørsholm, DK HQ | Locations Rockville, US HQ | Locations Wrocław, PL HQ Allschwil, CH | |
Employees | Employees 9047% decrease | Employees 13 | Employees 5,6695% decrease | Employees 138% increase | Employees 882% increase |
Valuation ($) | Valuation ($) 171.2 m | Valuation ($) N/A | Valuation ($) 8.8 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $75.7m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) ¥495.6b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income $19.7m (FY, 2021) | Net income N/A | Net income ¥59.9b (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 22.9m | Total funding raised $ 8m | Total funding raised N/A | Total funding raised $ 28.3m | Total funding raised N/A |
LiPlasome Pharma is a biotech company focused on oncology.
View companyKyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View companyInnovative Cellular Therapeutics (ICT, 斯丹赛生物技术) is a biotechnology company focused on the development of cellular immunotherapies for the treatment of cancer.
View companyCaptor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases.
View company